Search results
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
Fortune via Yahoo Finance· 2 weeks agoBrad Miller is helping Moderna shift from its reliance on COVID vaccines, with the company hoping to...
Moderna sues Pfizer, BioNTech over COVID-19 vaccine patents
Associated Press via Yahoo News· 2 years agoCOVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main...
Moderna inks deal to make mRNA medicines in China
CNN Business via Yahoo Finance· 10 months agoUS drugmaker Moderna has signed a deal to make mRNA medicines in China as part of its first major investment in the country, despite escalating trade and...
Moderna CEO Blasted for Planned Covid Vaccine Price Hike
The Fiscal Times via Yahoo Finance· 1 year agoThe CEO of drugmaker Moderna came under fire from lawmakers Wednesday at a Senate hearing focused on...
Senators press Moderna CEO on COVID-19 vaccine price hike
AP Finance via Yahoo Finance· 1 year agoModerna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine...
Sliding vaccine sales, new costs, squeeze Moderna 4Q profit
Associated Press via Yahoo News· 1 year agoModerna’s fourth-quarter profit tumbled 70% as COVID-19 vaccine sales fell and the drugmaker caught...
Moderna tops 1Q forecasts; vaccine sales plunge as expected
AP Finance via Yahoo Finance· 12 months agoSales of Moderna’s COVID-19 vaccine plunged in the first quarter and some expenses soared, but Wall...
Moderna says its RSV vaccine is 84% effective in older adults
Live Science via Yahoo News· 1 year agoolder man wearing a blue surgical mask looks down at his arm, which bears a bandage as if he's just...
Why Moderna Stock Popped Today
Motley Fool· 1 year agoShares of Moderna (NASDAQ: MRNA) rose 4.6% on Monday after the drugmaker released encouraging clinical trial results for its new COVID-19 booster....
Moderna CEO to testify in senate on proposed vaccine price hike
Reuters via Yahoo News· 1 year agoIn January, Sanders had written to Bancel to refrain from quadrupling the price of COVID-19 vaccine,...